TNONW Tenon Medical, Inc.

Fundamentals / CIK 0001560293 / USD
Other share classes on CIK 0001560293: TNON

Tenon Medical, Inc. reported $5.57M in revenue and a net loss of $17.00M for the trailing twelve months ended September 30, 2026 (up 22.1% year over year), with a 66.9% gross margin and a -225.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TNONW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$5.88M$2.94M$0-$18.02MFY 2021 Revenue: $160KFY 2021 Net Income: -$7.05M2021FY 2022 Revenue: $691KFY 2022 Net Income: -$18.92M2022FY 2023 Revenue: $2.25MFY 2023 Net Income: -$15.58M2023FY 2024 Revenue: $3.28MFY 2024 Net Income: -$13.67M2024FY 2025 Revenue: $3.94MFY 2025 Net Income: -$12.56M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $3.94M $3.28M $2.25M $691K $160K
Cost of Revenue $1.59M $1.57M $1.69M $1.33M $55K
Gross Profit $2.36M $1.71M $1.24M -$641K $105K
Research & Development $2.15M $2.60M $3.16M $2.83M $1.72M
Selling, General & Admin $13.00M $12.87M $13.80M $15.26M $4.85M
Total Operating Expenses $15.15M $15.48M $16.97M $18.08M $6.57M
Operating Income -$12.79M -$13.77M -$15.73M -$18.73M -$6.46M
EBITDA -$12.53M -$13.36M -$15.53M -$18.65M -$6.46M
Interest Expense -- $34K $21K $354K $621K
Income Before Tax -- -- -- -$18.92M -$7.08M
Net Income -$12.56M -$13.67M -$15.58M -$18.92M -$7.05M
Basic EPS -$59.65 -$395.09 -$2,408.42 -$6,630.18 -$21,922.81
Diluted EPS -$59.65 -$395.09 -$2,408.42 -$6,630.18 -$21,922.81
Basic Shares Outstanding 210 35 6 3 0
Diluted Shares Outstanding 210 35 6 3 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.43M $1.28M $1.38M $1.48M $1.17M $564K $726K $770K
Cost of Revenue $482K $465K $434K $464K $400K $319K $403K $417K
Gross Profit $950K $814K $945K $1.02M $773K $245K $323K $353K
Research & Development $804K $768K $662K $527K $428K $503K $691K $569K
Selling, General & Admin $3.23M $3.40M $3.56M $3.36M $3.74M $2.60M $3.31M $2.96M
Total Operating Expenses $4.04M $4.17M $4.22M $3.88M $4.17M $3.10M $4.00M $3.53M
Operating Income -$3.08M -$3.35M -$3.28M -$2.87M -$3.39M -$2.86M -$3.68M -$3.17M
EBITDA -$3.01M -$3.29M -$3.19M -$2.77M -$3.31M -$2.81M -$3.63M -$3.06M
Interest Expense $719K $852K $176K -- -- -- -- $0
Net Income -$6.64M -$4.05M -$3.48M -$2.83M -$3.34M -$2.77M -$3.62M -$3.09M
Basic EPS -$5.39 -$12.35 -$10.88 -- -$14.17 -$12.76 -$35.44 --
Diluted EPS -$5.39 -$12.35 $10.88 -- -$14.17 -$12.76 $35.44 --
Basic Shares Outstanding 1.2K 328 321 -- 236 217 103 --
Diluted Shares Outstanding 1.2K 328 321 -- 236 217 103 --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.76M $6.54M $2.43M $2.13M $2.92M
Short-Term Investments -- -- -- $6.44M $4.40M
Cash & Short-Term Investments $3.76M $6.54M $2.43M $8.57M $7.32M
Accounts Receivable, Net $1.70M $863K $518K $228K $76K
Inventory $1.05M $606K $554K $415K $188K
Total Current Assets $6.77M $8.21M $3.89M $9.35M $7.67M
Property, Plant & Equipment, Net $918K $752K $961K $793K $101K
Goodwill $2.41M -- -- -- --
Intangible Assets $485K -- -- -- --
Total Non-Current Assets $3.99M $1.63M $2.46M $1.74M $1.60M
Total Assets $10.76M $9.84M $6.34M $11.09M $9.27M
Accounts Payable $845K $369K $433K $550K $478K
Total Current Liabilities $3.21M $1.87M $3.14M $2.53M $15.27M
Total Non-Current Liabilities $2.51M $2.00M $2.43M $2.31M $911K
Total Liabilities $5.72M $3.87M $5.57M $4.84M $16.18M
Total Debt (incl. Leases) $141K $428K $684K $911K $1.11M
Common Stock $11K $3.0K $3.0K $1.0K $1.0K
Retained Earnings -$81.30M -$68.75M -$55.07M -$39.49M -$20.57M
Accumulated Other Comp. Income -- -- -$46K -$100K -$91K
Total Stockholders' Equity $5.04M $5.97M $778K $6.25M -$20.55M
Total Equity $5.04M $5.97M $778K $6.25M -$20.55M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $8.27M $1.68M $4.61M $3.76M $3.44M $7.85M $10.31M $6.54M
Cash & Short-Term Investments $8.27M $1.68M $4.61M $3.76M $3.44M $7.85M $10.31M $6.54M
Accounts Receivable, Net $1.70M $1.95M $1.97M $1.70M $1.31M $770K $886K $863K
Inventory $882K $783K $806K $1.05M $1.36M $688K $607K $606K
Total Current Assets $11.22M $4.81M $7.62M $6.77M $6.54M $9.88M $11.99M $8.21M
Property, Plant & Equipment, Net $717K $771K $901K $918K $663K $842K $698K $752K
Goodwill $2.41M $2.41M $2.41M $2.41M $2.41M -- -- --
Intangible Assets $441K $455K $470K $485K $500K -- -- --
Total Non-Current Assets $4.98M $5.12M $5.22M $3.99M $3.82M $1.23M $1.40M $1.63M
Total Assets $16.20M $9.92M $12.84M $10.76M $10.37M $11.11M $13.39M $9.84M
Accounts Payable $657K $628K $646K $845K $625K $894K $496K $369K
Total Current Liabilities $3.83M $8.30M $7.41M $3.21M $3.04M $2.56M $2.19M $1.87M
Total Non-Current Liabilities $3.15M $3.36M $3.54M $2.51M $2.53M $1.84M $1.82M $2.00M
Total Liabilities $6.98M $11.66M $10.94M $5.72M $5.57M $4.40M $4.02M $3.87M
Total Debt (incl. Leases) $1.29M $1.35M $1.40M $141K $216K $290K $360K $428K
Common Stock $3.0K -- $11K $11K $9.0K $8.0K $8.0K $3.0K
Retained Earnings -$95.47M -$88.83M -$84.78M -$81.30M -$78.47M -$75.13M -$72.36M -$68.75M
Total Stockholders' Equity $9.22M -$1.74M $1.90M $5.04M $4.80M $6.71M $9.38M $5.97M
Total Equity $9.22M -$1.74M $1.90M $5.04M $4.80M $6.71M $9.38M $5.97M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$12.56M -$13.67M -$15.58M -$18.92M -$7.08M
Depreciation & Amortization $262K $408K $199K $78K $2.0K
Stock-Based Compensation $1.69M $3.85M $4.14M $2.90M $377K
Change in Receivables -$851K -$386K -$290K -$152K -$61K
Change in Inventory -$387K -$52K -$139K -$227K -$145K
Change in Payables $486K -$64K -$117K $72K $444K
Operating Cash Flow -$10.74M -$9.88M -$12.18M -$12.03M -$4.29M
Capital Expenditure -$273K -$186K -$361K -$847K -$102K
Free Cash Flow -$11.02M -$10.06M -$12.54M -$12.87M -$4.39M
Purchases of Investments -- -- -- -$10.12M -$4.40M
Sales & Maturities of Investments -- -- -- $8.08M $0
Investing Cash Flow -$1.02M -$186K $6.14M -$2.88M -$4.50M
Common Stock Issued -- $2.11M $495K $14.14M $0
Financing Cash Flow $8.99M $14.12M $6.30M $14.11M $11.47M
Net Change in Cash -$2.78M $4.11M $299K -$788K $2.67M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$6.64M -$4.05M -$3.48M -$2.83M -$3.34M -$2.77M -$3.62M -$3.09M
Depreciation & Amortization $76K $60K $88K $95K $77K $48K $42K $117K
Stock-Based Compensation $120K $412K $331K $344K $58K $417K $872K $883K
Change in Receivables $249K $27K -$282K -$403K -$541K $116K -$23K $18K
Change in Inventory -$99K $280K $248K $167K -$484K -$81K $11K $1.0K
Change in Payables $29K -$18K -$199K $220K -$259K $398K $127K -$724K
Operating Cash Flow -$2.39M -$2.76M -$2.96M -$2.22M -$3.82M -$2.21M -$2.48M -$2.78M
Capital Expenditure -$8.0K -$172K -$56K -- -- -- -- $37K
Free Cash Flow -$2.40M -$2.93M -$3.02M -- -- -- -- -$2.74M
Investing Cash Flow -$8.0K -$172K -$56K -- -- -- -- $37K
Common Stock Issued -- -- -- -- -- $0 $4.01M -$57K
Financing Cash Flow $8.99M $0 $3.87M $2.73M $59K -$59K $6.26M $113K
Net Change in Cash $6.59M -$2.93M $851K $314K -$4.40M -$2.46M $3.78M -$2.63M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 59.8% 52.2% 55.2% -92.8% 65.6%
Operating Margin -324.3% -420.1% -699.0% -2709.8% -4038.1%
Net Profit Margin -318.4% -417.2% -692.5% -2737.6% -4405.0%
Return on Equity (ROE) -249.1% -229.0% -2002.7% -302.6% --
Return on Assets (ROA) -116.7% -138.9% -245.6% -170.6% -76.0%
Current Ratio 2.11x 4.39x 1.24x 3.69x 0.50x
Quick Ratio 1.78x 4.07x 1.06x 3.53x 0.49x
Debt to Equity 0.03x 0.07x 0.88x 0.15x --
Revenue Growth (YoY) +20.4% +45.6% +225.6% +331.9% --
Gross Profit Growth (YoY) +37.8% +37.9% -- -710.5% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 66.9% 66.8% 64.8% 59.8% 52.4% 45.4% 47.6% 52.2%
Operating Margin -225.9% -242.7% -269.6% -324.3% -405.2% -438.5% -424.4% -420.1%
Net Profit Margin -305.1% -257.9% -270.1% -318.4% -396.3% -429.5% -417.6% -417.2%
Return on Equity (ROE) -184.4% -- -655.2% -249.1% -267.0% -188.5% -146.3% -229.0%
Return on Assets (ROA) -104.9% -138.0% -96.7% -116.7% -123.6% -113.9% -102.4% -138.9%
Current Ratio 2.93x 0.58x 1.03x 2.11x 2.15x 3.86x 5.46x 4.39x
Quick Ratio 2.70x 0.48x 0.92x 1.78x 1.70x 3.59x 5.19x 4.07x
Debt to Equity 0.14x -- 0.74x 0.03x 0.05x 0.04x 0.04x 0.07x
Revenue Growth (YoY) +22.1% +126.8% +89.9% +92.3% +32.2% -37.4% +1.0% -4.7%
Gross Profit Growth (YoY) +22.9% +232.2% +192.6% +188.1% +84.9% -47.9% -31.3% -36.9%
Source: SEC EDGAR CompanyFacts (CIK 0001560293) · from March 31, 2021 Data through September 30, 2026 · synced Nov 21, 2026, 05:14 UTC · Open in terminal